Percutaneous lung thermo-ablation

Jean Palussière; Vittorio Catena; Jean Yves Gaubert; Xavier Buy; Thierry de Baere

doi:10.1016/j.bulcan.2017.03.010

Percutaneous lung thermo-ablation

Jean Palussière, Vittorio Catena, Jean Yves Gaubert, Xavier Buy, Thierry de Baere

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Abstract

Percutaneous lung thermo-ablation has steadily been developed over the past 15 years. Main indications are early stage non-small cell lung carcinoma (NSCLC) for non-surgical patients and slow evolving localized metastatic disease, either spontaneous or following a general treatment. Radiofrequency, being the most evaluated technique, offers a local control rate of about 80–90% for tumors < 3 cm in diameter. With excellent tolerance and very few complications, radiofrequency may be proposed for patients with a chronic disease. Other ablation techniques under investigation such as microwaves and cryotherapy could allow overcoming radiofrequency limits. Furthermore, stereotactic radiotherapy proposed for the same indications is efficient. Comparative studies are warranted to differentiate these techniques in terms of efficacy, tolerance and cost-effectiveness.

Translated title of the contribution	Thermo-ablation pulmonaire percutanée
Original language	English
Pages (from-to)	417-422
Number of pages	6
Journal	Bulletin du Cancer
Volume	104
Issue number	5
DOIs	https://doi.org/10.1016/j.bulcan.2017.03.010
Publication status	Published - 1 May 2017

Keywords

Cryotherapy
Lung metastasis
Micro-waves
NSCLC
Radiofrequency
Tumoral ablation

Access to Document

10.1016/j.bulcan.2017.03.010

Cite this

@article{703a704d050d4213b26685507b91a206,

title = "Percutaneous lung thermo-ablation",

abstract = "Percutaneous lung thermo-ablation has steadily been developed over the past 15 years. Main indications are early stage non-small cell lung carcinoma (NSCLC) for non-surgical patients and slow evolving localized metastatic disease, either spontaneous or following a general treatment. Radiofrequency, being the most evaluated technique, offers a local control rate of about 80–90% for tumors < 3 cm in diameter. With excellent tolerance and very few complications, radiofrequency may be proposed for patients with a chronic disease. Other ablation techniques under investigation such as microwaves and cryotherapy could allow overcoming radiofrequency limits. Furthermore, stereotactic radiotherapy proposed for the same indications is efficient. Comparative studies are warranted to differentiate these techniques in terms of efficacy, tolerance and cost-effectiveness.",

keywords = "Cryotherapy, Lung metastasis, Micro-waves, NSCLC, Radiofrequency, Tumoral ablation",

author = "Jean Palussi{\`e}re and Vittorio Catena and Gaubert, {Jean Yves} and Xavier Buy and {de Baere}, Thierry",

note = "Publisher Copyright: {\textcopyright} 2017 Soci{\'e}t{\'e} Fran{\c c}aise du Cancer",

year = "2017",

month = may,

day = "1",

doi = "10.1016/j.bulcan.2017.03.010",

language = "English",

volume = "104",

pages = "417--422",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "5",

}

TY - JOUR

T1 - Percutaneous lung thermo-ablation

AU - Palussière, Jean

AU - Catena, Vittorio

AU - Gaubert, Jean Yves

AU - Buy, Xavier

AU - de Baere, Thierry

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Percutaneous lung thermo-ablation has steadily been developed over the past 15 years. Main indications are early stage non-small cell lung carcinoma (NSCLC) for non-surgical patients and slow evolving localized metastatic disease, either spontaneous or following a general treatment. Radiofrequency, being the most evaluated technique, offers a local control rate of about 80–90% for tumors < 3 cm in diameter. With excellent tolerance and very few complications, radiofrequency may be proposed for patients with a chronic disease. Other ablation techniques under investigation such as microwaves and cryotherapy could allow overcoming radiofrequency limits. Furthermore, stereotactic radiotherapy proposed for the same indications is efficient. Comparative studies are warranted to differentiate these techniques in terms of efficacy, tolerance and cost-effectiveness.

AB - Percutaneous lung thermo-ablation has steadily been developed over the past 15 years. Main indications are early stage non-small cell lung carcinoma (NSCLC) for non-surgical patients and slow evolving localized metastatic disease, either spontaneous or following a general treatment. Radiofrequency, being the most evaluated technique, offers a local control rate of about 80–90% for tumors < 3 cm in diameter. With excellent tolerance and very few complications, radiofrequency may be proposed for patients with a chronic disease. Other ablation techniques under investigation such as microwaves and cryotherapy could allow overcoming radiofrequency limits. Furthermore, stereotactic radiotherapy proposed for the same indications is efficient. Comparative studies are warranted to differentiate these techniques in terms of efficacy, tolerance and cost-effectiveness.

KW - Cryotherapy

KW - Lung metastasis

KW - Micro-waves

KW - NSCLC

KW - Radiofrequency

KW - Tumoral ablation

UR - http://www.scopus.com/inward/record.url?scp=85018958690&partnerID=8YFLogxK

U2 - 10.1016/j.bulcan.2017.03.010

DO - 10.1016/j.bulcan.2017.03.010

M3 - Review article

C2 - 28477869

AN - SCOPUS:85018958690

SN - 0007-4551

VL - 104

SP - 417

EP - 422

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 5

ER -

Percutaneous lung thermo-ablation

Abstract

Keywords

Access to Document

Other files and links

Cite this